Predominantly BCR-ABL negative myeloid precursors in interferon-α treated chronic myelogenous leukemia: A follow-up study of peripheral blood colony-forming cells with fluorescence in situ hybridization

Annals of Hematology

Volumn 80, Issue 1, 2001, Pages 9-16

  Sick, C ^a   Schultheis, B ^b   Pasternak, G ^b   Kottke, I ^b   Horner S ^b   Heissig, B ^b   Hehlmann, R ^b  

^a Katharina Kasper gGmbH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chronic myelogenous leukemia; Hematopoietic progenitor cells; Interferon

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; BUSULFAN; CYTARABINE; HYDROXYUREA;

ADVANCED CANCER; ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CELL COUNT; CELL LINEAGE; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CLONOGENESIS; COLONY FORMING CELL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC TEST; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; METAPHASE CHROMOSOME; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN ANALYSIS; STEM CELL; TARGET CELL; TREATMENT OUTCOME;

FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; LONGITUDINAL STUDIES;

EID: 0035132040     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000237     Document Type: Article

References (37)

1. UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response
2. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization
3. Regulated proliferation of primitive progenitor cells in long-term human marrow cultures
4. 1) chromosome
5. New understanding of the pathogenesis of CML: A prototype of early neoplasia
6. Evaluation of cytogenetic conversion to Ph-negative haematopoiesis in long-term bone marrow culture for patients with chronic myeloid leukaemia on conventional hydroxyurea therapy, on pulse-dose hydroxyurea and on interferon-alpha
7. BCR-ABL, ABL-BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia
8. Interferon-α overrides the deficient adhesion of chronic myelogenous leukemia primitive progenitor cells to bone marrow stromal cells
9. Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML)
10. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
11. Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukaemia
12. Management of chronic myeloid leukaemia
13. Chronic myelogenous leukemia: Does interferon alpha prolong life (editorial)?
14. Randomized comparison of interferon-α with busulfan and hydroxyurea in chronic myelogenous leukemia
15. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-α therapy by competitive polymerase chain reaction
16. A statistically significant sex difference in the number of colony-forming cells from human peripheral blood
17. Chronic myelogenous leukemia: A concise update
18. Treatment of chronic myelogenous leukemia: Current status and investigational options
19. Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia
20. Circulating colony-forming cells in different stages of chronic myelocytic leukemia
21. In vitro colony formation by normal and leukemic human hematopoietic cells: Characterization of the colony forming cells
22. A minute chromosome in human granulocytic leukemia
23. Persistence of bcr-abl mRNA-expressing cells in long-term cultures established from chronic myeloid leukemic bone marrow or blood
24. Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?
25. Molecular response of CML patients treated with interferon-α monitored by quantitative Southern blot analysis
26. The Philadelphia chromosome translocation. A paradigm for understanding leukemia
27. Value of molecular monitoring during the treatment of chronic myeloid leukemia: A cancer and leukemia group B study
28. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients
29. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia
30. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia
31. Interferon symbol α-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia
32. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: Interphase fluorescence in situ hybridization compared with RT-PCR
33. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization
34. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level
35. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients
36. Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia
37. Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatment